Pancreatic cancer – What's next?

Presse Med. 2019 Mar;48(3 Pt 2):e187-e197. doi: 10.1016/j.lpm.2019.02.031. Epub 2019 Mar 14.

[Article in French]

Authors

Roberto Salvia¹, Fabio Casciani², Elisabetta Sereni¹, Claudio Bassi¹

Affiliations

¹ University of Verona Hospital Trust, The Pancreas Institute, Unit of General and Pancreatic Surgery, Verona, Italy.
² University of Verona Hospital Trust, The Pancreas Institute, Unit of General and Pancreatic Surgery, Verona, Italy. Electronic address: fabio.casciani01@gmail.com.

PMID: 30878338
DOI: 10.1016/j.lpm.2019.02.031

Abstract

This chapter focuses on the most recent advantages in the medical treatment of localized pancreatic cancer.

Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Publication types

Review

MeSH terms

Ablation Techniques
Antineoplastic Agents, Immunological / therapeutic use
Cancer Vaccines
Chemotherapy, Adjuvant
Clinical Trials as Topic
Genetic Therapy
Humans
Immunotherapy
Neoadjuvant Therapy
Oncolytic Virotherapy
Pancreatic Neoplasms / genetics
Pancreatic Neoplasms / therapy*
Tumor Hypoxia

Substances

Antineoplastic Agents, Immunological
Cancer Vaccines